Venlafaxine in treatment of generalized anxiety disorder / 中国新药与临床杂志

ABSTRACT

AIM: To study the efficacy and adverse reactions of venlafaxine in the treatment of generalized anxiety disorder.　METHODS: Twenty-one patients (M 13, F 8; age 33 a± s 16 a) with diagnosis of generalized anxiety disorder according to CCMD-Ⅱ-R were treated with venlafaxine 50 mg*d-1 for 4 wk. Patients were assessed with the HAMA and TESS and routine experimental examination before and after treatment.　RESULTS: Venlafaxine was obvious effective to generalized anxiety disorder. The effectiveness appeared after 1 wk. The remarkable effective rate was 76% at 4 wk. The main adverse reactions of venlafaxine were thirst, sweating nausea and headache etc. 　CONCLUSION: Venlafaxine is an effective and safe drug in the treatment of generalized anxiety disorder.